Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment.
Turco L, Taru MG, Vitale G, Stefanescu H, Mirici Cappa F, Berardi S, Baldan A, Di Donato R, Pianta P, Vero V, Vizioli L, Procopciuc LM, Procopet B, Morelli MC, Piscaglia F. Turco L, et al. Among authors: piscaglia f. Clin Gastroenterol Hepatol. 2024 Aug 30:S1542-3565(24)00780-8. doi: 10.1016/j.cgh.2024.08.012. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39209198 Free article.
High bone fracture risk in a large modern cohort of liver transplant recipients.
Zavatta G, Vitale G, Morelli MC, Pianta P, Turco L, Cappa FM, Ravaioli M, Cescon M, Piscaglia F, Altieri P, Pagotto U; BOLTBO study group ; Francesca Caputo; Luca Vizioli; Sonia Berardi; Vittoria Vero; Anna Baldan; Roberto Di Donato; Letizia Anna Marcantoni; Mariachiara Corrado. Zavatta G, et al. Among authors: piscaglia f. Intern Emerg Med. 2024 Sep 27. doi: 10.1007/s11739-024-03767-5. Online ahead of print. Intern Emerg Med. 2024. PMID: 39331313
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FWG, Valla D, Garcia-Pagan JC; VALDIG Investigators. De Gottardi A, et al. Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19. Liver Int. 2017. PMID: 27778440 Free article.
Metabolic disorders across hepatocellular carcinoma in Italy.
Morisco F, Guarino M, Valvano MR, Auriemma F, Farinati F, Giannini EG, Ciccarese F, Tovoli F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cabibbo G, Felder M, Benvengù L, Gasbarrini A, Svegliati Baroni G, Foschi FG, Biasini E, Masotto A, Virdone R, Marra F, Caporaso N, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Morisco F, et al. Liver Int. 2018 Nov;38(11):2028-2039. doi: 10.1111/liv.13877. Epub 2018 Jun 19. Liver Int. 2018. PMID: 29745475 Free article.
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
Iavarone M, Alimenti E, Tada T, Shimose S, Suda G, Yoo C, Soldà C, Piscaglia F, Tosetti G, Marra F, Vivaldi C, Conti F, Schirripa M, Iwamoto H, Sho T, Lee SH, Rizzato MD, Tonnini M, Rimini M, Campani C, Masi G, Foschi F, Bruccoleri M, Kawaguchi T, Kumada T, Hiraoka A, Atsukawa M, Fukunishi S, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Hatanaka T, Kakizaki S, Kawata K, Tada F, Ohama H, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Casadei-Gardini A, Lampertico P. Iavarone M, et al. Among authors: piscaglia f. Liver Cancer. 2023 Sep 14;13(2):215-226. doi: 10.1159/000534127. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751557 Free PMC article.
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.
Cucchetti A, Trevisani F, Pecorelli A, Erroi V, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Giannini EG, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Baroni GS, Virdone R, Bernardi M, Pinna AD; Italian Liver Cancer Group. Cucchetti A, et al. J Hepatol. 2014 Aug;61(2):333-41. doi: 10.1016/j.jhep.2014.03.037. Epub 2014 Apr 6. J Hepatol. 2014. PMID: 24717522
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma.
Tovoli F, Pallotta DP, Vivaldi C, Campani C, Federico P, Palloni A, Dalbeni A, Soldà C, Lani L, Svegliati-Baroni G, Garajova I, Ielasi L, De Lorenzo S, Granito A, Stefanini B, Masi G, Marra F, Lonardi S, Brandi G, Daniele B, Auriemma A, Schiadà L, Chen R, Piscaglia F; ARTE study group. Tovoli F, et al. Among authors: piscaglia f. Dig Liver Dis. 2024 Dec;56(12):2079-2084. doi: 10.1016/j.dld.2024.07.035. Epub 2024 Aug 20. Dig Liver Dis. 2024. PMID: 39168753 Free article.
449 results